Differential exon-specific gene expression profiling (GEP) in Sca-1+ splenocytes after treatment (n = 3) compared to untreated HR-MDS mice (n = 3) revealed 1952 genes differentially expressed upon treatment, distributed into two distinct cluster groups (Figure 4A). This evidence concerns the gene CASP3 and myelodysplastic syndrome.